To tackle medication errors throughout the European Union, stakeholders in healthcare are being called upon to work together to improve reporting and prevention strategies. Collaboration is needed among national patient safety authorities,...
Thomas Forissier favors an aggressive, comprehensive approach for tackling medication non-adherence, and for good reason. U.S. pharmaceutical companies are losing $188 billion each year because of non-adherence, according to analysis conducted by his...
Pharma Tech Industries (PTI), Royston, GA (PTI), has been selected to handle filling, assembly, and packaging services for a migraine relief medication administered through the OptiNose Delivery system.
Medical Device and Diagnostic Industry (MD+DI) and strategic alliance partner ITG Market Research, a division of ITG, recently published a landmark study on The Medical Device Outsourcing Landscape: Current & Future Trends, 2013-2018. The...
Antares Pharma, Inc. today announced that the New Drug Application (NDA) for OTREXUP, a potential new product for the subcutaneous delivery of methotrexate (MTX) using Medi-Jet technology, has been accepted by the U.S. Food and Drug Administration (...
Sunovion Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration has accepted for review the Company’s New Drug Application resubmission for STEDESA (eslicarbazepine acetate) for use as a once-daily adjunctive therapy in the...
MedVantx Inc., the company that created the first ever controlled access to generic samples in US physician offices, today highlighted it's MedStart Connect program as a solution to the problem specified in a recent study published in JAMA...
Araxes Pharma LLC announced today it has entered into an exclusive arrangement with Janssen Biotech, Inc. to develop first-in-class therapeutics against a certain target for the treatment of cancer.
Persistent Systems, the global leader in software product and technology services, today announced the immediate availability of PaxPharma, a compliance-based, Design to Print (D2P) automation solution designed specifically for pharmaceutical...
Persistent Systems, the global leader in software product and technology services, today announced the immediate availability of PaxPharma, a compliance-based, Design to Print (D2P) automation solution designed specifically for pharmaceutical...